J9174 Docetaxel (beizray) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Docetaxel (beizray)

Brand Name:

Beizray

Strength:

1mg

HCPCS:

J9174

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimitotic Agent

Minor Drug Class:

Taxane

Oral (Y/N):

No

FDA Approval Year:

2024

FDA Discontinuation Year:

CMS Effective Date:

July 9, 2025

CMS Discontinuation Date:

Status:

In Use